Details for New Drug Application (NDA): 080381
✉ Email this page to a colleague
NDA 080381 describes TREMIN, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the TREMIN profile page.
The generic ingredient in TREMIN is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
The generic ingredient in TREMIN is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
Summary for 080381
| Tradename: | TREMIN |
| Applicant: | Schering |
| Ingredient: | trihexyphenidyl hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080381
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
